Who Paid My Doc
Howard Saal
Clinical Genetics (M.D.) Cincinnati, OH Medical Doctor
NPI 1801827308 CMS profile 1211760
3333 Burnet Ave, Ml 4006, Cincinnati, OH 45229
General payments
$121,356
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$824,325
Through program year 2025, Howard Saal of Cincinnati, OH is reported in the CMS Open Payments database as having received $121,356 across 133 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $824,325 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,050 | 2 | |
| 2024 | General | $18,330 | 9 | |
| 2023 | General | $13,296 | 17 | |
| 2022 | General | $15,872 | 18 | |
| 2021 | General | $11,975 | 12 | |
| 2020 | General | $10,942 | 11 | |
| 2019 | General | $48,891 | 64 |
Beside peers
- Howard Saal
- Clinical Genetics (M.D.) median
- Middle half of Clinical Genetics (M.D.)
- National median
In program year 2025, general payments to Howard Saal were reported at $2,050. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.
Show as a table
| Year | Howard Saal | Clinical Genetics (M.D.) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $48,891 | $130 | $24–$2,691 | $163 |
| 2020 | $10,942 | $126 | $30–$3,700 | $114 |
| 2021 | $11,975 | $185 | $30–$3,777 | $132 |
| 2022 | $15,872 | $136 | $44–$2,749 | $149 |
| 2023 | $13,296 | $196 | $55–$5,220 | $160 |
| 2024 | $18,330 | $165 | $46–$3,171 | $164 |
| 2025 | $2,050 | $255 | $85–$3,583 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
133 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Genetics (M.D.) in Ohio
Robert Hopkin
Clinical Genetics (M.D.) · Cincinnati, OH
Angelika Erwin
Clinical Genetics (M.D.) · Cleveland, OH
Gregory Grabowski
Clinical Genetics (M.D.) · Cincinnati, OH
Laura Konczal
Clinical Genetics (M.D.) · Cleveland, OH
Loren Pena
Clinical Genetics (M.D.) · Cincinnati, OH
Kathryn Weaver
Clinical Genetics (M.D.) · Cincinnati, OH
Related records
Clinical Genetics (M.D.) in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Genetics (M.D.)
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.